Detalles de la búsqueda
1.
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report.
Anticancer Drugs
; 33(10): 1171-1174, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206104
2.
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis.
Anal Chem
; 88(16): 8091-8, 2016 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27498854
3.
Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.
Radiology
; 280(1): 151-60, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26807894
4.
Abiraterone and increased survival in metastatic prostate cancer.
N Engl J Med
; 364(21): 1995-2005, 2011 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21612468
5.
Evaluation of the possible interference of abiraterone therapy on testosterone immunoassay.
Clin Chem Lab Med
; 57(10): e253-e254, 2019 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30875318
6.
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.
BJU Int
; 109(2): 200-6, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22212284
7.
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.
Target Oncol
; 17(4): 467-474, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35751733
8.
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
J Clin Pathol
; 75(1): 39-44, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33144356
9.
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14).
Front Oncol
; 11: 787835, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34900742
10.
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis.
Eur Urol Oncol
; 3(2): 176-182, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307958
11.
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
JAMA Netw Open
; 3(10): e2021692, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112397
12.
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region.
Clin Genitourin Cancer
; 17(1): e187-e194, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30448106
13.
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.
Eur Urol
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772788
14.
Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT).
Anticancer Res
; 28(3B): 1767-71, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18630457
15.
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer.
Clin Cancer Res
; 20(23): 5908-17, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25231405
16.
Safety and tolerability of pazopanib in the treatment of renal cell carcinoma.
Expert Opin Drug Saf
; 11(5): 851-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22861374
17.
Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.
Am J Clin Oncol
; 35(2): 105-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21325939
18.
The changing therapeutic landscape of castration-resistant prostate cancer.
Nat Rev Clin Oncol
; 8(10): 597-610, 2011 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21826082
19.
Changing therapeutic paradigms in castrate-resistant prostate cancer.
Clin Genitourin Cancer
; 8(1): 17-22, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21208851
20.
Horizon scanning for novel therapeutics for the treatment of prostate cancer.
Expert Opin Investig Drugs
; 19(12): 1487-502, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20868208